Evidence map›Paper›PMID 38902523›Full record

ArticleScientific reports2024

Explainable prediction model for the human papillomavirus status in patients with oropharyngeal squamous cell carcinoma using CNN on CT images.

Annarita Fanizzi, Maria Colomba Comes, Samantha Bove, Elisa Cavalera, Paola de Franco, Alessia Di Rito, Angelo Errico, Marco Lioce, Francesca Pati, Maurizio Portaluri and 6 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Annarita FanizziLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Maria Colomba ComesLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy. m.c.comes@oncologico.bari.it.
Samantha BoveLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy. s.bove@oncologico.barit.it.
Elisa CavaleraRadiation Oncology Unit, Dipartimento di Oncoematologia, Ospedale Vito Fazzi, Lecce, Italy.
Paola de FrancoRadiation Oncology Unit, Dipartimento di Oncoematologia, Ospedale Vito Fazzi, Lecce, Italy.
Alessia Di RitoOspedale Monsignor Raffaele Dimiccoli, Barletta, Italy.
Angelo ErricoOspedale Monsignor Raffaele Dimiccoli, Barletta, Italy.
Marco LioceUnità Operativa Complessa di Radioterpia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Francesca PatiRadiotherapy Department, ASL Brindisi, Brindisi, Italy.
Maurizio PortaluriRadiotherapy Department, ASL Brindisi, Brindisi, Italy.
Concetta SaponaroUnità Operativa Complessi di Anatomia Patologia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Giovanni ScognamilloUnità Operativa Complessa di Radioterpia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Ippolito TroianoRadiation Oncology Department, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Michele TroianoRadiation Oncology Department, Fondazione IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Italy.
Francesco Alfredo ZitoUnità Operativa Complessi di Anatomia Patologia, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Raffaella MassafraLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Funding

Ministero della Salute RC2024
6 · The paper itself

Abstract

Several studies have emphasised how positive and negative human papillomavirus (HPV+  and HPV-, respectively) oropharyngeal squamous cell carcinoma (OPSCC) has distinct molecular profiles, tumor characteristics, and disease outcomes. Different radiomics-based prediction models have been proposed, by also using innovative techniques such as Convolutional Neural Networks (CNNs). Although some of these models reached encouraging predictive performances, there evidence explaining the role of radiomic features in achieving a specific outcome is scarce. In this paper, we propose some preliminary results related to an explainable CNN-based model to predict HPV status in OPSCC patients. We extracted the Gross Tumor Volume (GTV) of pre-treatment CT images related to 499 patients (356 HPV+ and 143 HPV-) included into the OPC-Radiomics public dataset to train an end-to-end Inception-V3 CNN architecture. We also collected a multicentric dataset consisting of 92 patients (43 HPV+ , 49 HPV-), which was employed as an independent test set. Finally, we applied Gradient-weighted Class Activation Mapping (Grad-CAM) technique to highlight the most informative areas with respect to the predicted outcome. The proposed model reached an AUC value of 73.50% on the independent test. As a result of the Grad-CAM algorithm, the most informative areas related to the correctly classified HPV+ patients were located into the intratumoral area. Conversely, the most important areas referred to the tumor edges. Finally, since the proposed model provided additional information with respect to the accuracy of the classification given by the visualization of the areas of greatest interest for predictive purposes for each case examined, it could contribute to increase confidence in using computer-based predictive models in the actual clinical practice.

Indexed as

Neural Networks, ComputerOropharyngeal NeoplasmsPapillomavirus InfectionsTomography, X-Ray ComputedAgedCarcinoma, Squamous CellFemaleHuman Papillomavirus VirusesHumansMaleMiddle AgedPapillomaviridaeSquamous Cell Carcinoma of Head and NeckTumor BurdenConvolutional neural networkExplainable artificial intelligenceGrad-CAMHuman papillomavirusOropharyngeal squamous cell carcinoma

Identifiers

PMID38902523
PMCPMC11189928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.